SuperworthCOMPASS Pathways market cap CMPS
Share price times shares outstanding: what the whole company sells for, since 2021.
- Today, Oct 23, 2026
- $1.5B
- Highest close in our data
- $2.1B
- Sep 2026
COMPASS Pathways is worth $1.5B at the close on Oct 23, 2026, at $11.18 a share.
That is up 157% over the last year and up 2% over five years.
Its highest close in our data was $2.1B in Sep 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.5B | $519.5M | $2.1B | +141% |
| 2025 | $641.4M | $238.8M | $647.2M | +135% |
| 2024 | $273M | $271.6M | $737.3M | −50% |
| 2023 | $541.6M | $242M | $541.6M | +58% |
| 2022 | $341.9M | $324.4M | $853.4M | −57% |
| 2021 | $794.1M | $794.1M | $1.8B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest COMPASS Pathways' size, closest first, today.
| Company | Market cap |
|---|---|
| CMPSCOMPASS Pathways | $1.5B |
| PAHCPhibro Animal Health | $1.6B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| ANIPANI Pharmaceuticals | $1.7B |
| OMEROmeros | $1.2B |
| HRMYHarmony Biosciences | $2.1B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| PBHPrestige Consumer Healthcare | $2.3B |
| NRIXNurix Therapeutics | $2.8B |
| ABUSArbutus Biopharma | $831M |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on COMPASS Pathways
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.